Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2025		Dec. 31, 2024
Current Assets
Cash and cash equivalents	$ 1,263		$ 962
Trade receivables - third party and affiliates, net	922		1,121
Non-trade receivables, net	545		493
Inventories	2,220		2,284
Assets held for sale	492		0
Other assets	251		266
Total current assets	5,693		5,126
Investments in affiliates	1,252		1,217
Property, plant and equipment, net	5,076		5,273
Operating lease right-of-use assets	359		388
Deferred income taxes	1,359		1,251
Other assets	601		555
Goodwill	4,171	[1]	5,387	[2]
Intangible assets, net	3,184		3,641
Total assets	21,695		22,838
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates	1,204		1,501
Trade payables - third party and affiliates	1,279		1,228
Liabilities held for sale	75		0
Other liabilities	1,049		1,157
Income taxes payable	76		4
Total current liabilities	3,683		3,890
Long-term debt, net of unamortized deferred financing costs	11,394		11,078
Deferred income taxes	512		923
Uncertain tax positions	208		286
Benefit obligations	344		396
Operating lease liabilities	265		294
Other liabilities	817		408
Commitments and Contingencies
Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]
Common stock, $0.0001 par value, 400,000,000 shares authorized (2025: 170,918,221 and 2024: 170,827,196 issued)	0		0
Treasury stock, at cost	(5,482)		(5,486)
Additional paid-in capital	431		409
Retained earnings	9,876		11,054
Accumulated other comprehensive income (loss), net	(776)		(848)
Total Celanese Corporation shareholders' equity	4,049		5,129
Noncontrolling interests	423		434
Total equity	4,472		5,563
Total liabilities and equity	$ 21,695		$ 22,838

[1] Includes accumulated impairment losses of $2.7 billion in the Engineered Materials segment.

[2] Includes accumulated impairment losses of $1.5 billion in the Engineered Materials segment.